Plain-English translation of NCT06890637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding a fecal microbiota transplant (a procedure where healthy gut bacteria from a donor are placed into your colon) and a special Crohn's disease exclusion diet can work better than the medication alone to control your Crohn's disease. You would receive the transplant several times over the study period and follow dietary guidance, while continuing your regular advanced Crohn's medication. The goal is to help people whose disease isn't fully controlled by medication alone.
Many people with active Crohn's disease don't get complete relief even with the strongest available medications—doctors call this 'hitting a ceiling.' Researchers believe that restoring healthy gut bacteria and removing foods that trigger inflammation might help the medication work better and give patients better control of their disease.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic multiple times over about one year. In the first 6 weeks, you would receive transplant procedures (or a sham procedure with sterile water) via colonoscopy at weeks 0, 2, and 6. If your disease improves, you would continue receiving treatments every 8 weeks through week 42. You would also follow either a special diet that eliminates certain inflammatory foods, or receive general dietary counseling, depending on which group you're assigned to. Throughout the study, you would continue taking your regular advanced Crohn's medication and have your disease monitored through clinic visits and blood tests.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
India